Tags: fda | ozempic | novo nordisk | kidney disease | chronic | cardiovascular | deaths

FDA Approves Ozempic for Chronic Kidney Disease

Ozempic cartridges
(Dreamstime)

Tuesday, 28 January 2025 02:49 PM EST

Novo Nordisk said on Tuesday the U.S. FDA has approved its diabetes drug Ozempic to reduce the risk of worsening kidney disease and death due to cardiovascular disease in adults with Type 2 diabetes and chronic kidney disease. 

© 2025 Thomson/Reuters. All rights reserved.


Health-News
Novo Nordisk said on Tuesday the U.S. FDA has approved its diabetes drug Ozempic to reduce the risk of worsening kidney disease and death due to cardiovascular disease in adults with Type 2 diabetes and chronic kidney disease....
fda, ozempic, novo nordisk, kidney disease, chronic, cardiovascular, deaths
38
2025-49-28
Tuesday, 28 January 2025 02:49 PM
Newsmax Media, Inc.

Sign up for Newsmax’s Daily Newsletter

Receive breaking news and original analysis - sent right to your inbox.

(Optional for Local News)
Privacy: We never share your email address.
Join the Newsmax Community
Read and Post Comments
Please review Community Guidelines before posting a comment.
 
Find Your Condition
Newsmax2 Live
 
On Now:9:00a ET • Salcedo Live
Coming Up:10:00a ET • The Wendy Bell Show
Get Newsmax Text Alerts

The information presented on this website is not intended as specific medical advice and is not a substitute for professional medical treatment or diagnosis. Read Newsmax Terms and Conditions of Service.

Newsmax, Moneynews, Newsmax Health, and Independent. American. are registered trademarks of Newsmax Media, Inc. Newsmax TV, and Newsmax World are trademarks of Newsmax Media, Inc.

NEWSMAX.COM
© 2025 Newsmax Media, Inc.
All Rights Reserved
NEWSMAX.COM
© Newsmax Media, Inc.
All Rights Reserved